Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Julphar
Fish and Richardson
Cerilliant
Mallinckrodt
Chubb
Novartis
Deloitte
QuintilesIMS

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014764

« Back to Dashboard

NDA 014764 describes ROBINUL, which is a drug marketed by Robins Ah, West-ward Pharms Int, and Casper Pharma Llc, and is included in three NDAs. It is available from five suppliers. Additional details are available on the ROBINUL profile page.

The generic ingredient in ROBINUL is glycopyrrolate. There are seventeen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
Summary for 014764
Tradename:ROBINUL
Applicant:Robins Ah
Ingredient:glycopyrrolate
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 014764

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.2MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Covington
Daiichi Sankyo
US Department of Justice
Harvard Business School
Baxter
Chinese Patent Office
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot